Petros Pharm Inc (PTPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,489 | 4,353 | 5,137 | 6,070 | 7,322 |
| TOTAL | $3,546 | $4,395 | $5,164 | $6,134 | $7,397 |
| Non-Current Assets | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $3,546 | $4,395 | $5,164 | $6,134 | $7,397 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 97 | 133 | 84 | 421 | 970 |
| Accrued Expenses | 217 | 191 | 143 | 512 | 261 |
| Other current liabilities | N/A | 2,299 | 1 | 3 | 4 |
| TOTAL | $2,845 | $2,623 | $2,293 | $2,765 | $2,950 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,845 | $2,623 | $2,293 | $2,765 | $2,950 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 42,372 | 42,372 | 42,372 | 42,372 | 42,372 |
| Common Shares | 4 | 4 | 4 | 4 | 4 |
| Retained earnings | -113,237 | -112,282 | -111,295 | -110,958 | -110,036 |
| TOTAL | $701 | $1,771 | $2,871 | $3,368 | $4,447 |
| Total Liabilities And Equity | $3,546 | $4,394 | $5,164 | $6,134 | $7,397 |